tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best Stocks to Buy Now, 10/16/2025, According to Top Analysts

3 Best Stocks to Buy Now, 10/16/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Caesars Entertainment (CZR) – Caesars Entertainment is a U.S. casino and hotel operator known for its resorts, gaming, and entertainment properties across North America. Today, J.P. Morgan analyst Daniel Politzer maintained a Buy rating on the stock and decreased the price target to $43 from $44 per share. Interestingly, seven out of the nine Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 71.15%. 

Waystar Holding Corp. (WAY) – This is a healthcare technology company that provides cloud-based payment and revenue cycle management solutions for hospitals and medical providers. Yesterday, TD Cowen analyst Charles Rhyee maintained a Buy rating on the stock with a price target of $54 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 36.81%.

MBX Biosciences (MBX) – MBX Biosciences is a clinical-stage biopharmaceutical company developing therapies for rare endocrine disorders. Yesterday, Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on the stock with a price target of $50 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 291.4%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclaimer & DisclosureReport an Issue

1